 GUANGZHOU, China, May 12, 2021 GLOBE NEWSWIRE -- Burning Rock Biotech Limited NASDAQ: BNR, the Company or Burning Rock, a company focused on the application of next generation sequencing NGS technology in the field of precision oncology, today announced that it will be included in the MSCI China Index, effective after the U.S. market close on May 27, 2021. Burning Rock is the only NGS-based precision oncology company from China that has been selected in the current MSCI semi-annual index review. 